Developing Probiotics as Foods and Drugs

This workshop will review the state of the science supporting clinical applications of probiotics in promoting and sustaining health and in the management of disease conditions. It will also explore how the current regulatory status of probiotics, which are marketed mostly as foods and dietary supplements in the United States, impacts the clinical evaluation of probiotics. Limitations and gaps in the current body of evidence, as well as scientific and regulatory hurdles, will be identified and recommendations will be provided regarding areas in need of future support. NIH is one of the cosponsors of the workshop.

Source: http://nccam.nih.gov/news/events/upcoming/index.htm#probiotics?nav=rss

chemical compound library

Related posts:

  1. NCCAM Grantsmanship Workshop
  2. ARQ 197 Tivantinib live database of drugs Administrative Region of Lombardy
  3. Safety of Probiotics Research Report
This entry was posted in Antibody. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>